Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
Relapsed Angioimmunoblastic T Cell Lymphoma with Fulminant Leukemic Involvement
Rahaf Altahan1,2, Areej AlMugairi2, Muhamed Hitham Almahayni3
1Hematology Section, Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
Angioimmunoblastic T cell lymphoma (AITL) is a rare, aggressive non-Hodgkin lymphoma. This case report highlights diagnostic challenges and a rare presentation of AITL with leukemic infiltration during relapse.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Angioimmunoblastic T cell lymphoma (AITL) is a rare non-Hodgkin lymphoma (1-2% of cases).
- AITL presents diagnostic challenges due to non-specific symptoms and often non-diagnostic initial biopsies.
- Curative therapeutic options remain limited, with challenges in stem cell transplantation (SCT) eligibility and post-transplant relapse.
Observation:
- This case report details an AITL patient with florid leukemic infiltration upon relapse.
- The report includes patient symptoms, diagnostic hurdles, clinical course, and treatment.
- Peripheral blood and flow cytometry images are provided for illustrative purposes.
Findings:
- Leukemic infiltration is a rare presentation of AITL.
- The case underscores the diagnostic difficulties and aggressive nature of AITL.
- This report contributes to the limited literature on AITL with leukemic features.
Implications:
- Enhanced understanding of AITL, particularly its rare presentations like leukemic infiltration.
- Improved diagnostic strategies for challenging cases of AITL.
- Potential insights into therapeutic approaches for relapsed or refractory AITL.
More Related Videos
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023